Analysis of COVID-19 Guideline Quality and Change of Recommendations: A Systematic Review.
Siya ZhaoShuya LuShouyuan WuZijun WangQiangqiang GuoQianling ShiHairong ZhangJuanjuan ZhangHui LiuYunlan LiuXianzhuo ZhangLing WangMengjuan RenPing WangHui LanQi ZhouYajia SunJin CaoQinyuan LiJanne EstillJoseph L MathewHyeong Sik AhnMyeong Soo LeeXiaohui WangChenyan ZhouYaolong ChenPublished in: Health data science (2021)
Both the methodological and reporting qualities of COVID-19 CPGs increased over time, but there is still room for further improvement. The lack of effective use of available evidence and management of conflicts of interest were the main reasons for the low quality of the CPGs. The use of formal rating systems for the quality of evidence and strength of recommendations may help to improve the quality of CPGs in the context of the COVID-19 pandemic. During the pandemic, we suggest developing a living guideline of which recommendations are supported by a systematic review for it can facilitate the timely translation of the latest research findings to clinical practice. We also suggest that CPG developers should register the guidelines in a registration platform at the beginning for it can reduce duplication development of guidelines on the same clinical question, increase the transparency of the development process, and promote cooperation among guideline developers all over the world. Since the International Practice Guideline Registry Platform has been created, developers could register guidelines prospectively and internationally on this platform.